Modulation of granulocyte kinetics by GM-CSF/IFN-γ in a human LPS rechallenge model

Journal of Leukocyte Biology

Volumn 94, Issue 3, 2013, Pages 513-520

  Kamp, Vera M ^a   Leentjens, Jenneke ^b   Pillay, Janesh ^a   Langereis, Jeroen D ^b   de Kleijn, Stan ^b   Kox, Matthijs ^b   Netea, Mihai G ^b   Pickkers, Peter ^b   Koenderman, Leo ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endotoxemia; Endotoxin tolerance; Eosinophil; Myeloid derived suppressor cells; Neutrophil

Indexed keywords

CD16 ANTIGEN; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; L SELECTIN; PLACEBO;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL MATURATION; CELL MOTILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FLOW CYTOMETRY; GRANULOCYTE; GRANULOCYTE FUNCTION; HUMAN; HUMAN EXPERIMENT; IMMUNOMODULATION; LEUKOCYTE; LEUKOCYTE COUNT; MALE; NEUTROPHIL; NEUTROPHIL COUNT; NEUTROPHILIA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; T LYMPHOCYTE;

ENDOTOXEMIA; ENDOTOXIN TOLERANCE; EOSINOPHIL; MYELOID-DERIVED SUPPRESSOR CELLS; NEUTROPHIL;

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; L-SELECTIN; LIPOPOLYSACCHARIDES; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883215389     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0213066     Document Type: Article

References (30)

1. Bone, R. C. (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24, 1125-1128.
2. Keel, M., Trentz, O. (2005) Pathophysiology of polytrauma. Injury 36, 691-709.
3. Mokart, D., Capo, C., Blache, J. L., Delpero, J. R., Houvenaeghel, G., Martin, C., Mege, J. L. (2002) Early postoperative compensatory antiinflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br. J. Surg. 89, 1450-1456.
4. Ni Choileain, N., Redmond, H. P. (2006) Cell response to surgery. Arch. Surg. 141, 1132-1140.
5. Cavaillon, J. M., Adib-Conquy, M. (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 10, 233.
6. Cavaillon, J. M., Adrie, C., Fitting, C., Adib-Conquy, M. (2003) Endotoxin tolerance: is there a clinical relevance? J. Endotoxin Res. 9, 101-107.
7. Cross, A. S. (2002) Endotoxin tolerance-current concepts in historical perspective. J. Endotoxin Res. 8, 83-98.
8. Bundschuh, D. S., Barsig, J., Hartung, T., Randow, F., Docke, W. D., Volk, H. D., Wendel, A. (1997) Granulocyte-macrophage colony-stimulating factor and IFN-γ restore the systemic TNF-κ response to endotoxin in lipopolysaccharide-desensitized mice. J. Immunol. 158, 2862-2871.
9. Kox, M., de Kleijn, S., Pompe, J. C., Ramakers, B. P., Netea, M. G., van der Hoeven, J. G., Hoedemaekers, C. W., Pickkers, P. (2011) Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia. Crit. Care Med. 39, 1866-1870.
10. Greisman, S. E., Woodward, C. L. (1970) Mechanisms of endotoxin tolerance. VII. The role of the liver. J. Immunol. 105, 1468-1476.
11. Mackensen, A., Galanos, C., Engelhardt, R. (1991) Modulating activity of interferon-γ on endotoxin-induced cytokine production in cancer patients. Blood 78, 3254-3258.
12. Meisel, C., Schefold, J. C., Pschowski, R., Baumann, T., Hetzger, K., Gregor, J., Weber-Carstens, S., Hasper, D., Keh, D., Zuckermann, H., Reinke, P., Volk, H. D. (2009) Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a doubleblind, randomized, placebo-controlled multicenter trial. Am. J. Respir. Crit. Care Med. 180, 640-648.
13. Nierhaus, A., Montag, B., Timmler, N., Frings, D. P., Gutensohn, K., Jung, R., Schneider, C. G., Pothmann, W., Brassel, A. K., Schulte Am Esch, J. (2003) Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis. Intensive Care Med. 29, 646-651.
14. Leentjens, J., Kox, M., Koch, R. M., Preijers, F., Joosten, L. A., van der Hoeven, J. G., Netea, M. G., Pickkers, P. (2012) Reversal of immunoparalysis in humans in vivo: a double-blind placebo-controlled randomized pilot-study. Am. J. Respir. Crit. Care Med. 186, 838-845.
15. Quesenberry, P., Halperin, J., Ryan, M., Stohlman Jr., F. (1975) Tolerance to the granulocyte-releasing and colony-stimulating factor elevating effects of endotoxin. Blood 45, 789-800.
16. Pillay, J., Kamp, V. M., van Hoffen, E., Visser, T., Tak, T., Lammers, J. W., Ulfman, L. H., Leenen, L. P., Pickkers, P., Koenderman, L. (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Invest. 122, 327-336.
17. Steward, W. P., Scarffe, J. H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G., Crowther, D. (1989) Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions-a phase I dose-toxicity study. Br. J. Cancer 59, 142-145.
18. Moore, M. A. (1991) The clinical use of colony stimulating factors. Annu. Rev. Immunol. 9, 159-191.
19. McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M., Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., Topley, N. (2003) Interplay between IFN-γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J. Clin. Invest. 112, 598-607.
20. Ramakers, B. P., de Goeij, M., van der Hoeven, J. G., Peters, W. H., Pickkers, P. (2009) Inflammation-induced hepatotoxicity in humans. Shock 31, 151-156.
21. Dorresteijn, M. J., van Eijk, L. T., Netea, M. G., Smits, P., van der Hoeven, J. G., Pickkers, P. (2005) Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J. Endotoxin Res. 11, 287-293.
22. Docke, W. D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H. D., Kox, W. (1997) Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 3, 678-681.
23. Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., Chilvers, E. R. (2010) Neutrophil kinetics in health and disease. Trends Immunol. 31, 318-324.
24. Jersmann, H. P., Hii, C. S., Ferrante, J. V., Ferrante, A. (2001) Bacterial lipopolysaccharide and tumor necrosis factor α synergistically increase expression of human endothelial adhesion molecules through activation of NF-κB and p38 mitogen-activated protein kinase signaling pathways. Infect. Immun. 69, 1273-1279.
25. Dale, D. C., Liles, W. C., Llewellyn, C., Price, T. H. (1998) Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers. Am. J. Hematol. 57, 7-15.
26. Cain, D. W., Snowden, P. B., Sempowski, G. D., Kelsoe, G. (2011) Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism. PLoS One 6, e19957.
27. Suratt, B. T., Young, S. K., Lieber, J., Nick, J. A., Henson, P. M., Worthen, G. S. (2001) Neutrophil maturation and activation determine anatomic site of clearance from circulation. Am. J. Physiol. Lung Cell Mol. Physiol. 281, L913-L921.
28. De Bruin, A. M., Libregts, S. F., Valkhof, M., Boon, L., Touw, I. P., Nolte, M. A. (2012) IFNγ induces monopoiesis and inhibits neutrophil development during inflammation. Blood 119, 1543-1554.
29. Kanters, D., ten Hove, W., Luijk, B., van Aalst, C., Schweizer, R. C., Lammers, J. W., Leufkens, H. G., Raaijmakers, J. A., Bracke, M., Koenderman, L. (2007) Expression of activated Fc γ RII discriminates between multiple granulocyte-priming phenotypes in peripheral blood of allergic asthmatic subjects. J. Allergy Clin. Immunol. 120, 1073-1081.
30. Orr, Y., Taylor, J. M., Cartland, S., Bannon, P. G., Geczy, C., Kritharides, L. (2007) Conformational activation of CD11b without shedding of Lselectin on circulating human neutrophils. J. Leukoc. Biol. 82, 1115-1125.